Literature DB >> 32138446

The adrenal gland in AIDS.

Heidrun Rotterdam1, Francine Dembitzer1.   

Abstract

The adrenal gland has been known to be a common site of opportunistic infections and tumors that define the acquired immunodeficiency syndrome (AIDS) ever since the first autopsy data were published. We have examined the adrenal glands of 66 AIDS patients autopsied in New York City and tabulated and graded the findings in an attempt to estimate the likelihood of adrenal insufficiency developing on the basis of these lesions. AIDSdefining conditions were found in the adrenal glands of 56% of patients, primarily opportunistic infections (53%) and much less frequently neoplasms (3%). Cytomegaloviral (CMV) infection was by far the most common type (42%), followed by mycobacterial (8%) and fungal infections (3%). There was one case eachof Kaposi's sarcoma and lymphoma. Total necrosis of adrenal cortex was restricted to 2 cases of tuberculosis. CMV adrenalitis, although the most common infection and often associated with necrosis, never resulted in more than 30% destruction of the cortex. We conclude that although histopathological evidence of adrenal disease is common in AIDS, most such lesions are not sufficiently extensive to result in adrenal insufficiency. In contrast to previous reports stressing the importance of CMV adrenalitis as a possible cause of adrenocortical insufficiency, we now find tuberculosis the more likely cause of total cortical destruction.

Entities:  

Keywords:  Acquire Immunodeficiency Syndrome; Adrenal Gland; Adrenal Insufficiency; Adrenal Medulla; Suramin

Year:  1993        PMID: 32138446     DOI: 10.1007/BF02914483

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  49 in total

1.  [Epidemiological and pathomorphological autopsy findings in AIDS].

Authors:  E Bierhoff; A Weiss; K Tschubel; U Pfeifer
Journal:  Verh Dtsch Ges Pathol       Date:  1991

2.  The human immunodeficiency virus and the adrenal medulla.

Authors:  C D Weiss
Journal:  Ann Intern Med       Date:  1986-08       Impact factor: 25.391

3.  Adrenal gland lesions with murine cytomegalovirus.

Authors:  J D Shanley; E L Pesanti
Journal:  Ann Intern Med       Date:  1984-05       Impact factor: 25.391

4.  Adrenal necrosis in the acquired immunodeficiency syndrome.

Authors:  M L Tapper; H Z Rotterdam; C W Lerner; K Al'Khafaji; P A Seitzman
Journal:  Ann Intern Med       Date:  1984-02       Impact factor: 25.391

5.  Necropsy findings in acquired immunodeficiency syndrome: a comparison of premortem diagnoses with postmortem findings.

Authors:  A N Hui; M N Koss; P R Meyer
Journal:  Hum Pathol       Date:  1984-07       Impact factor: 3.466

6.  Disseminated Pneumocystis carinii infection causing extrapulmonary organ failure: clinical, pathologic, and immunohistochemical analysis.

Authors:  R J Cote; M Rosenblum; E E Telzak; M May; P D Unger; R W Cartun
Journal:  Mod Pathol       Date:  1990-01       Impact factor: 7.842

7.  Cytomegalovirus infection in the acquired immunodeficiency syndrome. Clinical and autopsy findings.

Authors:  E C Klatt; D Shibata
Journal:  Arch Pathol Lab Med       Date:  1988-05       Impact factor: 5.534

8.  Disseminated Pneumocystis carinii infection in a patient with acquired immunodeficiency syndrome.

Authors:  P D Unger; M Rosenblum; S E Krown
Journal:  Hum Pathol       Date:  1988-01       Impact factor: 3.466

Review 9.  Autopsy pathology in the acquired immune deficiency syndrome.

Authors:  C M Reichert; T J O'Leary; D L Levens; C R Simrell; A M Macher
Journal:  Am J Pathol       Date:  1983-09       Impact factor: 4.307

10.  Patho-anatomical studies in patients dying of AIDS.

Authors:  S Laulund; J Visfeldt; L Klinken
Journal:  Acta Pathol Microbiol Immunol Scand A       Date:  1986-05
View more
  1 in total

1.  The Thyroid in Acquired Immunodeficiency Syndrome.

Authors:  Marcus K. Lima; Leandro L. Freitas; Cristiano Montandon; Dalmo C. Filho; Mario L. Silva-Vergara
Journal:  Endocr Pathol       Date:  1998       Impact factor: 4.056

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.